Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
Neuropsychopharmacology. 1999 Mar;20(3):226-47. doi: 10.1016/S0893-133X(98)00075-X.
Neuropsychopharmacology. 1999.
PMID: 10063483